最新ニュース Celestica (NYSE:CLS) 株価情報

Celestica

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

Celestica Inc

Exchange Listed Funds Trust Cabana Target Leading Sector Aggressive ETF

Exchange Listed Funds Trust Cabana Target Leading Sector Conservative ETF

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical Inc

Trust for Professional Managers Convergence Long/Short Equity ETF

CLS HOLDINGS USA INC by CLS Holdings USA, Inc.

CLS Holdings USA Inc

Cleanspark Inc

Cabana Target Leading Sector Moderate ETF

CANADIAN LIFE COS SPLT by CANADIAN LIFE COS SPLIT CORP.

Canadian Life Companies Split Corp

Catalyst Bancorp Inc

CHINA OIL & GAS GROUP LTD by China Oil & Gas Group, Ltd.

China Oil And Gas Group Ltd

WIIM

AAOI

AIOT

BBAI

BOXL

BTBT

CDNS

Core Scientific, Inc. - Class A Common Stock

CORZ

ERIC

FICO

MOBBW

MPWR

NVDA

OUST

PSTG

QMCO

SatixFy Communications Ltd. Ordinary Share

SATX

SGMA

SNOW

TWLO

UMAC

VRAR

VRME

Shares of companies within the broader tech sector are trading higher amid overall market strength after CPI data was in line with estimates and core CPI rose by less than expected.

Celestica's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) short percent of float has fallen 15.04% since its last report. The company recently reported that it has 2.41 million shares sold short, which is 2.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.52 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Celestica Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736946917_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celestica has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Celestica's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celestica's peer group average for short interest as a percentage of float is 3.06%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(CLS) - Analyzing Celestica's Short Interest

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) stock gained 27.97% last week after the company <a href="https://www.benzinga.com//node/42912519" target="_blank" rel="noreferrer noopener">reported better-than-expected</a> first-quarter financial results.</li>
<li>Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) stock jumped 25.80% after the company announced an agreement to acquire Calpine Corp., an electricity generation company, in a cash and stock <a href="https://www.benzinga.com//node/42916941" target="_blank" rel="noreferrer noopener">deal valued at $16.4 billion</a>.</li>
<li>FTAI Aviation Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) shares escalated by 20.48%.</li>
<li>TD SYNNEX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) stock was up 15.05% after the company reported better-than-expected <a href="https://www.benzinga.com//node/42915528" target="_blank" rel="noreferrer noopener">fourth-quarter financial results</a>.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) shares grew 14.59% after the company announced a partnership with NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Continental AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CTTAF#OTC">CTTAF</a>) to scale driverless trucks using NVIDIA's <a href="https://www.benzinga.com//node/42841305" target="_blank" rel="noreferrer noopener">next-gen DRIVE Thor SoC</a>.</li>
<li>Royalty Pharma plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) shares are up 14.35% after the company announced it <a href="https://www.benzinga.com//node/42902266" target="_blank" rel="noreferrer noopener">increased its quarterly dividend</a>.</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) shares rose 13.75%. The company announced an expansion of its collaboration with Pure Storage to develop high-capacity, energy-efficient <a href="https://www.benzinga.com//node/42853369" target="_blank" rel="noreferrer noopener">solutions using Micron G9 QLC NAND</a>.</li>
<li>Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) stock upped 13.34% after the company reported better-than-expected<a href="https://www.benzinga.com//node/42912208" target="_blank" rel="noreferrer noopener"> results and issued 2025 guidance</a>.</li>
<li>Intra-Cellular Therapies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) stock gained 12.62%, entering into a settlement agreement with Sandoz and resolving a patent litigation related to CAPLYTA Patent.</li>
<li>United Airlines Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) surged 12.24% in sympathy with Delta Air Lines, which rose after reporting strong <a href="https://www.benzinga.com//node/42919651" target="_blank" rel="noreferrer noopener">fourth-quarter financial results</a>.</li>
</ol>
Photo by VanderWolf via Shutterstock

Large Cap

News

Movers

CTTAF

FTAI

ITCI

RPRX

SNAP

Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?

Celestica shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from $75 to $115.

RBC Capital analyst Paul Treiber maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Outperform and raises the price target from $75 to $115.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on Celestica, Raises Price Target to $115

AIRE

APLD

ASAN

AVGO

BLBX

CCTG

CFLT

COHR

CRDO

CRWD

DOCU

ESTC

FORTY

GOOG

GOOGL

GTLB

HUBS

IREN

MANH

MSFT

NVNI

OKTA

PLTR

PRCH

RCAT

RDZN

SHOP

SKYT

SMCI

WKEY

WULF

Shares of companies in the broader tech sector are trading lower after experiencing strong gains in 2024 amid AI momentum.

AKAM

AKTS

ALRM

ANET

BELFB

BLND

BLZE

CRSR

CTSH

CVLT

DELL

DOCN

DTST

EPAM

FFIV

FSLY

GDDY

IDAI

IMMR

INGM

KEYS

KODK

LASR

LIDR

LITE

MLGO

NOVT

NTAP

ONDS

OPTX

ORKT

PLUS

POWI

SIMO

TRMB

TTMI

VNET

VSAT

Shares of companies within the broader tech sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

Celestica shares are trading higher after Stifel raised its price target on the stock from $70 to$100.

Stifel analyst Matthew Sheerin maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Buy and raises the price target from $70 to $100.

Stifel Maintains Buy on Celestica, Raises Price Target to $100

Celestica's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) short percent of float has risen 15.62% since its last report. The company recently reported that it has 3.41 million shares sold short, which is 2.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Celestica Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732905923_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celestica has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Celestica's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celestica's peer group average for short interest as a percentage of float is 2.88%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Celestica's Recent Short Interest

Celestica shares are trading lower after UBS initiated coverage on the stock with a Neutral rating and announced a price target of $95.

In the latest quarter, 8 analysts provided ratings for Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $74.88, a high estimate of $95.00, and a low estimate of $58.00. Witnessing a positive shift, the current average has risen by 20.13% from the previous average price target of $62.33.
<img src="https://www.benzinga.com/files/images/story/2024/1732287615_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Celestica by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Vogt</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$95.00</td>
<td>-</td>
</tr>
<tr>
<td>George Wang</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$91.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Chan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Matthew Sheerin</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Paul Treiber</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Thanos Moschopoulos</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$72.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Daniel Chan</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Matthew Sheerin</td>
<td>Stifel</td>
<td>Maintains</td>
<td>Buy</td>
<td>$58.00</td>
<td>$58.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celestica. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Celestica compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Celestica's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Celestica's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CLS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celestica analyst ratings.</a>
<h2>Unveiling the Story Behind Celestica</h2>
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.
<h3>Celestica: A Financial Overview</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Celestica's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 22.33%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Celestica's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.67% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.06%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Celestica's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.55% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.52, Celestica adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings For Celestica

UBS analyst David Vogt initiates coverage on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Neutral rating and announces Price Target of $95.

Initiation

UBS Initiates Coverage On Celestica with Neutral Rating, Announces Price Target of $95

Investors with a lot of money to spend have taken a bearish stance on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CLS, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 13 options trades for Celestica.
This isn't normal.
The overall sentiment of these big-money traders is split between 46% bullish and 53%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $29,000, and 12, calls, for a total amount of $3,259,794.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $27.5 to $100.0 for Celestica over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Celestica stands at 542.89, with a total volume reaching 7,498.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Celestica, situated within the strike price corridor from $27.5 to $100.0, throughout the last 30 days.
<h3>Celestica 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732043739_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.3</td>
<td>$21.6</td>
<td>$22.1</td>
<td>$85.00</td>
<td>$2.2M</td>
<td>3.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$23.0</td>
<td>$22.3</td>
<td>$22.4</td>
<td>$62.50</td>
<td>$257.6K</td>
<td>453</td>
<td>130</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$57.0</td>
<td>$54.8</td>
<td>$57.0</td>
<td>$27.50</td>
<td>$171.0K</td>
<td>122</td>
<td>30</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.15</td>
<td>$2.05</td>
<td>$2.05</td>
<td>$95.00</td>
<td>$153.7K</td>
<td>304</td>
<td>762</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$15.9</td>
<td>$15.3</td>
<td>$15.3</td>
<td>$80.00</td>
<td>$87.2K</td>
<td>37</td>
<td>583</td>
</tr>
</tbody>
</table>

<h3>About Celestica</h3>
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.
In light of the recent options history for Celestica, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Celestica Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,051,582, the CLS's price is up by 3.49%, now at $86.9. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 69 days.</li>
</ul>
<h3>Expert Opinions on Celestica</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $75.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays has revised its rating downward to Overweight, adjusting the price target to $91. 
&#x2A; An analyst from BMO Capital has decided to maintain their Outperform rating on Celestica, which currently sits at a price target of $72. 
&#x2A; An analyst from Stifel persists with their Buy rating on Celestica, maintaining a target price of $70. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Celestica with a target price of $75. 
&#x2A; An analyst from TD Cowen persists with their Buy rating on Celestica, maintaining a target price of $70. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Celestica options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Spotlight on Celestica: Analyzing the Surge in Options Activity

AEIS

ALGM

AWRE

CAMT

CGNX

CLMB

CMTL

CNXN

CSCO

DGII

DIOD

EVLV

EXTR

FLEX

FORM

FRSH

IONQ

IPGP

NTCT

NVEC

Next Technology Holding Inc. - Ordinary Shares

NXTT

OSIS

PLXS

PMTS

QTWO

SANM

SCSC

SITM

VIAV

WOLF

ZBRA

Shares of companies within the broader technology sector are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

Celestica shares are trading higher after Barclays initiated coverage on the stock with an Overweight rating and announced a price target of $91.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/64f99e440313770001b5ef69/george-wang">Barclays analyst George Wang</a> initiated coverage on Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with an Overweight rating and announced a price target of $91. Celestica shares closed at $72.32 on Monday. <a href="https://www.benzinga.com/quote/CLS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Tessa Romero initiated coverage on Upstream Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPB#NASDAQ">UPB</a>) with an Overweight rating and announced a price target of $38. Upstream Bio shares closed at $25.15 on Monday. <a href="https://www.benzinga.com/quote/UPB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5901e8ea0bd9910001e193f8/margaret-kaczor">William Blair analyst Margaret Kaczor</a> initiated coverage on CeriBell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) with an Outperform rating. CeriBell shares closed at $26.24 on Monday. <a href="https://www.benzinga.com/quote/CBLL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Julien Dumoulin-Smith initiated coverage on CMS Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Buy rating and announced a price target of $76. CMS Energy shares closed at $68.39 on Monday. <a href="https://www.benzinga.com/quote/CMS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Bernstein analyst Chad Dillard initiated coverage on Eaton Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with an Outperform rating and announced a price target of $382. Eaton shares closed at $331.13 on Monday. <a href="https://www.benzinga.com/quote/ETN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ETN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="534" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05080021/image-28-1024x534.png" alt="" class="wp-image-630210" style="width:662px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05080021/image-28-1024x534.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05080021/image-28-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05080021/image-28-768x400.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05080021/image-28.png 1261w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41740698/top-3-health-care-stocks-youll-regret-missing-in-november">Top 3 Health Care Stocks You&#8217;ll Regret Missing In November</a></li>
</ul>

Pre-Market Outlook

CBLL

This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Barclays analyst George Wang initiates coverage on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight rating and announces Price Target of $91.

Barclays Initiates Coverage On Celestica with Overweight Rating, Announces Price Target of $91

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) stock upped 49.86% after the company announced it dosed its first patients in its Phase 1 clinical study of CAR-NK cell therapy for relapsed <a href="https://www.benzinga.com//node/41516867" target="_blank" rel="noreferrer noopener">B-Cell Non-Hodgkin Lymphoma</a>.</li>
<li>Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares rocketed 41.43% after the company reported better-than-expected first-quarter results and issued FY25 and second-quarter <a href="https://www.benzinga.com//node/41487340" target="_blank" rel="noreferrer noopener">revenue guidance above estimates</a>. Analysts boosted the <a href="https://www.benzinga.com/quote/lrn/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) <a href="https://www.benzinga.com//node/41409452" target="_blank" rel="noreferrer noopener">shares jumped 32.21%</a>.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) stock gained 31.68% last week. The stock has been volatile ahead of the upcoming U.S. election.</li>
<li>ZEEKR Intelligent Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>) gained 29.31%. Several U.S.-listed Chinese stocks gained after the People's Bank of China <a href="https://www.benzinga.com//node/41547149" target="_blank" rel="noreferrer noopener">injected 700 billion yuan</a> ($98.36 billion) into the banking system through its one-year medium-term lending facility, keeping the rate steady at 2.0%.</li>
<li>IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) stock gained 27.52%.</li>
<li>Herc Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRI#NYSE">HRI</a>) shares upped 21.76% after the company reported better-than-expected third-quarter revenue results and raised its FY24 equipment <a href="https://www.benzinga.com//node/41455862" target="_blank" rel="noreferrer noopener">rental revenue growth outlook</a>.</li>
<li>TeraWulf Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) stock gained 18.59% amid the rise in Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price. The company also proposed to raise $425 million via convertible senior debt notes.</li>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) stock escalated 20.76% after the company announced that it was granted FDA clearance for its 510(k) submission related to prior design changes <a href="https://www.benzinga.com//node/41462205" target="_blank" rel="noreferrer noopener">made to the Zio AT device</a>.</li>
<li>Celestica, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) shares rose 19.99% after the company reported better-than-expected third-quarter results and issued Q4 revenue guidance above estimates. Several analysts raised <a href="https://www.benzinga.com//node/41523564" target="_blank" rel="noreferrer noopener">the price target on the stock</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41560908/tesla-li-auto-and-microstrategy-are-among-top-10-large-cap-gainers-last-week-oct-21-oct-25-are-the" target="_blank" rel="noreferrer noopener">Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41561358/genuine-parts-company-universal-health-services-and-topbuild-are-among-top-10-large-cap-losers-las" target="_blank" rel="noreferrer noopener">Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Mid Cap

$BTC

IBRX

IRTC

Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

TD Cowen analyst Daniel Chan maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Buy and raises the price target from $68 to $70.

TD Cowen Maintains Buy on Celestica, Raises Price Target to $70

Top 10 Stocks For 2025

Barclays lays out 2025 thoughts on Apple, networking and other areas of tech

Comments

Celestica

ニュース

最新ニュース Celestica (NYSE:CLS) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル